Holen Sie sich die Stockscreener-App
1.82
5.81%
0.10
Handel nachbörslich:
1.82
Proqr Therapeutics N V Aktie (PRQR) Neueste Nachrichten
ProQR Therapeutics NV earnings beat by €0.02, revenue topped estimates - Investing.com India
ProQR Therapeutics (NASDAQ:PRQR) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Citizens reiterates ProQR Therapeutics stock rating on RNA editing platform potential - Investing.com
ProQR Therapeutics (NASDAQ:PRQR) Coverage Initiated at Oppenheimer - MarketBeat
ProQR Therapeutics Q4 2025 Financial Results: Loss of $9.1MNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
ProQR: Q4 Earnings Snapshot - 10TV
ProQR Posts 2025 Results as Axiomer RNA Editing Pipeline Advances and Cash Runway Extends to Mid-2027 - TipRanks
ProQR (PRQR) Advances Clinical Trials Amid Reduced Cash Holdings - GuruFocus
ProQR Therapeutics (NASDAQ: PRQR) details 2025 loss, cash runway and RNA editing focus - Stock Titan
Biotech ProQR ends 2025 with €92.4M cash, eyes key trial readout in 2026 - Stock Titan
ProQR: Fourth Quarter Financial Overview - Bitget
Analysts Set ProQR Therapeutics Price Target at $7.14 - National Today
ProQR Therapeutics NV expected to post a loss of 10 cents a shareEarnings Preview - TradingView
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Quarterly Risk: Can ProQR Therapeutics NV weather a recession2025 Big Picture & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Weekly Trades: Is ProQR Therapeutics NV backed by strong institutional buyingJuly 2025 Pullbacks & Verified Momentum Stock Alerts - baoquankhu1.vn
Highs Report: Is ProQR Therapeutics NV a strong candidate for buy and holdMarket Growth Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Portfolio Shifts: Can ProQR Therapeutics NV benefit from deglobalization2025 Market Sentiment & AI Forecasted Stock Moves - baoquankhu1.vn
Is ProQR Therapeutics NV backed by strong institutional buyingWeekly Trend Recap & Risk Controlled Daily Plans - baoquankhu1.vn
Retinitis Pigmentosa Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc - Barchart.com
ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference - 富途牛牛
Surprises Report: Is ProQR Therapeutics NV a potential multi baggerWeekly Market Summary & Expert Approved Trade Ideas - baoquankhu1.vn
PRQR Should I Buy - Intellectia AI
Retail Trends: Is ProQR Therapeutics NV a potential multi baggerJuly 2025 Momentum & Risk Managed Investment Signals - baoquankhu1.vn
Aberdeen Group plc Grows Position in ProQR Therapeutics N.V. $PRQR - Defense World
Can ProQR Therapeutics N.V. weather a recession2025 Fundamental Recap & Low Drawdown Momentum Ideas - mfd.ru
ProQR Therapeutics (PRQR) Leadership to Discuss Company Developm - GuruFocus
Aug Shorts: Is ProQR Therapeutics NV stock a buy or sellProfit Target & High Return Stock Watch Alerts - baoquankhu1.vn
How interest rate cuts could boost ProQR Therapeutics N.V. stockProfit Target & Real-Time Buy Signal Notifications - mfd.ru
What’s the RSI of ProQR Therapeutics N.V. stock2025 Big Picture & Community Verified Trade Alerts - mfd.ru
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 47.2% in January - MarketBeat
Can ProQR Therapeutics N.V. withstand a market correctionCPI Data & Community Verified Watchlist Alerts - mfd.ru
Is ProQR Therapeutics N.V. currently under institutional pressureChart Signals & Long-Term Growth Portfolio Plans - mfd.ru
PRQR PE Ratio & Valuation, Is PRQR Overvalued - Intellectia AI
Will ProQR Therapeutics N.V. stock recover after earningsPortfolio Gains Summary & Weekly High Conviction Trade Ideas - mfd.ru
A | Is ProQR Therapeutics N.V. stock showing strong momentumJuly 2025 Levels & Risk Controlled Swing Alerts - mfd.ru
Aug Levels: Is ProQR Therapeutics NV stock a buy or sellJuly 2025 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
ProQR announces board changes as two members set to depart By Investing.com - Investing.com Canada
ProQR announces board changes as two members set to depart - Investing.com
ProQR Therapeutics (PRQR) Announces Board Changes at Upcoming AG - GuruFocus
ProQR Announces Planned Changes to Board Composition - markets.businessinsider.com
ProQR Therapeutics Plans Board Changes as Co-Founder and Director Exit at 2026 AGM - TipRanks
Myriad Genetics (NASDAQ:MYGN) & ProQR Therapeutics (NASDAQ:PRQR) Head-To-Head Survey - Defense World
ProQR Aktie: Pipeline-Fortschritte - Börse Global
Risk Recap: Will ProQR Therapeutics NV stock recover after earningsJuly 2025 Highlights & Capital Efficient Trading Techniques - baoquankhu1.vn
Dip Buying: Is Sharps Technology Inc Equity Warrant in a bullish channelWeekly Market Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Gains Recap: Is ProQR Therapeutics NV a cyclical or defensive stockEarnings Trend Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Quarterly Earnings: Can ProQR Therapeutics NV weather a recessionWeekly Stock Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
ProQR Therapeutics N.V. (NASDAQ:PRQR) Not Doing Enough For Some Investors As Its Shares Slump 28% - 富途牛牛
Aug PreEarnings: Is KFFB stock undervalued right nowTrade Entry Report & Weekly Stock Performance Updates - baoquankhu1.vn
Market Recap: Can SBEV be recession proofQuarterly Trade Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Obesity Market on Track for Major Expansion by 2034, According to DelveInsight | Rhythm Pharmaceuticals, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharm - Barchart.com
Earnings Miss: Can ProQR Therapeutics NV reach resistance levels soon2025 AllTime Highs & Expert Verified Movement Alerts - baoquankhu1.vn
Trading Recap: Is Alumis Inc gaining market shareJuly 2025 Market Mood & Growth Focused Entry Point Reports - baoquankhu1.vn
Day Trade: Does OLMA have strong EBITDA marginsJuly 2025 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Published on: 2026-01-18 21:01:57 - baoquankhu1.vn
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):